Eliem Therapeutics
Balance Sheet

Last updated:

The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has Eliem Therapeutics's balance sheet done over the years? Its assets were worth $110,469,000 last year, which is less than in the previous period. 3% of Eliem Therapeuticsโ€™s total assets is currently financed by debt. Its liabilities reached the amount of $2,870,000, which means an decrease by -54% compared compared to last year.

Debt to Assets

Eliem Therapeutics, Inc. (NASDAQ:ELYM): Debt to assets
2019 21395000 783K 3.66%
2020 24631000 3.06M 12.44%
2021 173241000 6.03M 3.49%
2022 134992000 6.27M 4.65%
2023 110469000 2.87M 2.6%

ELYM Balance Sheet (2019 โ€“ 2023)

2023 2022 2021 2020 2019
Assets
Current assets:
Cash and cash equivalents
93.11M43.58M46.92M20.48M21.22M
Short term investments
13.68M79.98M89.55M00
Net receivables
2.02M6.49M6.52M00
Inventory
0-6.49M4.39M00
Other current assets
1.43M10.82M852K11K35K
Total current assets
110.25M134.39M148.25M21.99M21.28M
Non-current assets:
Property, Plant and Equipment
199K471K000
Goodwill
00000
Intangible assets
00000
Long term investments
0024.91M00
Other non-current assets
14.99K128K70K2.63M112K
Total non-current assets
213.99K599K24.98M2.63M112K
Total assets
110.46M134.99M173.24M24.63M21.39M
Liabilities
Current liabilities:
Accounts payable
Deferred revenue
-66K0000
Short term debt
668K300K000
Total current liabilities
2.83M6.09M6.03M3.06M783K
Non-current liabilities:
Long term debt
30K180K000
Deferred tax
00000
Other non-current liabilities
7K07K00
Total non-current liabilities
36.99K180K7K00
Total liabilities
2.87M6.27M6.03M3.06M783K
Data sourceData sourceData source